sk&f-38393 has been researched along with nitroarginine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Starr, BS; Starr, MS | 1 |
Brus, R; Kostrzewa, RM; Nowak, P; Szkilnik, R | 1 |
3 other study(ies) available for sk&f-38393 and nitroarginine
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Do NMDA receptor-mediated changes in motor behaviour involve nitric oxide?
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Arginine; Male; Mice; Motor Activity; Nitric Oxide; Nitroarginine; Phenethylamines; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, N-Methyl-D-Aspartate; Reserpine | 1995 |
Nitro-l-arginine attenuates SKF 38393-induced oral activity in neonatal 6-hydroxydopamine-lesioned rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Animals, Newborn; Catalepsy; Dopamine Agonists; Drug Interactions; Enzyme Inhibitors; Female; Male; NG-Nitroarginine Methyl Ester; Nitroarginine; Oxidopamine; Rats; Rats, Wistar; Sympatholytics; Yawning | 1997 |